Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Titel:
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Auteur:
Correa, Rohann J.M. Morton, Gerard Chung, Hans T. Tseng, Chia-Lin Cheung, Patrick Chu, William Liu, Stanley K McGuffin, Merrylee Shahid, Anam Davidson, Melanie Ravi, Ananth Helou, Joelle Alayed, Yasir Zhang, Liying Mamedov, Alexandre Loblaw, Andrew